Robert Walker
Emergency Medicine · Hazlehurst, MSNPI 1649216680
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 362 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 13.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,090 and has fallen 59.4% since, to $442 in 2025. Among emergency medicine clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 362 payments — averaging $14.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$686
- Novartis$608
- GSK$602
- AstraZeneca$537
- Novo Nordisk$514
- Lilly USA, LLC$319
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,274100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 74 | $686 |
| Novartis | 41 | $608 |
| GSK | 42 | $602 |
| AstraZeneca | 34 | $537 |
| Novo Nordisk | 29 | $514 |
| Lilly USA, LLC | 21 | $319 |
| Global Blood Therapeutics, Inc. | 15 | $286 |
| Boehringer Ingelheim | 11 | $278 |
| Merck | 16 | $257 |
| Mylan Specialty L.p. | 9 | $200 |
| AbbVie(2 entities) | 24 | $199 |
| Sumitomo Pharma America, Inc. | 6 | $117 |
| Astellas Pharma US Inc | 7 | $107 |
| Sanofi-aventis U.S. LLC | 6 | $97 |
| Lundbeck LLC | 3 | $71 |
| Vanda Pharmaceuticals Inc. | 3 | $65 |
| Abbott | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Dexcom, Inc. | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Siemens Medical Solutions USA, Inc. | 1 | $25 |
| Amgen | 1 | $23 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $21 |
| Evoke Pharma, Inc. | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Boston Scientific | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$125
- AREXVY$125
- Tresiba$124
- JARDIANCE$120
How this compares
$5,274 in reported general payments places this provider in the 95th percentile of 443 emergency medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 213 | $130,841 |
| LinzessLinaclotide | 137 | $116,657 |
| JardianceEmpagliflozin | 139 | $104,426 |
| OzempicSemaglutide | 53 | $83,238 |
| TrulicityDulaglutide | 62 | $81,832 |
| JanuviaSitagliptin Phosphate | 109 | $73,961 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 76 | $69,857 |
| Tresiba Flextouch U-200Insulin Degludec | 41 | $47,220 |
| XareltoRivaroxaban | 49 | $39,314 |
| EntrestoSacubitril/Valsartan | 54 | $36,190 |
| RybelsusSemaglutide | 18 | $27,596 |
| MyrbetriqMirabegron | 36 | $25,424 |
| MounjaroTirzepatide | 14 | $23,732 |
| FarxigaDapagliflozin Propanediol | 18 | $15,256 |
| TrintellixVortioxetine Hydrobromide | 18 | $11,667 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $686 | $130,841213 claims |
| AbbVieLinzess, Synthroid, Combigan | $199 | $122,265195 claims |
| Boehringer IngelheimJardiance, Jentadueto | $278 | $112,284152 claims |
| Novo NordiskOzempic, Rybelsus | $514 | $110,83471 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $319 | $105,56376 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $602 | $87,252108 claims |
| MerckJanuvia | $257 | $73,961109 claims |
| NovartisEntresto | $608 | $36,19054 claims |
| Astellas Pharma US IncMyrbetriq | $107 | $25,42436 claims |
| AstraZenecaFarxiga | $537 | $15,25618 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $39 | $11,66718 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $15 | $9,05223 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 443 emergency medicine providers in Mississippi.
Other emergency medicine in Hazlehurst
- Kenneth WhittingtonHazlehurst$8K
- Stanley ThompsonSouthaven$466K
- Utsav NandiJackson$54K
- Richard SummersJackson$20K
- Damon DarseyJackson$11K
- Samuel Richardson IiiJackson$8K
- Joseph PongettiJackson$5K
- Salvador ArceoBrandon$5K
- Manuel OngCarthage$5K
- Jessica JonesJackson$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.